About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Sep 29, 2022...
REHOVOT, ISRAEL—September 29, 2022—Cancer tumors contain multiple species of fungi that differ per tumor type, according to a large study led by researchers at the Weizmann Institute of Science and the University of California, San Diego.
The study, published today in Cell, potentially has implications for the diagnosis and treatment of cancer, as well as for the detection of cancer through a blood test. It complements scientists’ understanding of the interaction between cancer cells and the bacteria that exist in tumors alongside fungi, bacteria that have been shown to affect cancer growth, metastasis, and response to therapy. The researchers systematically profiled fungal communities in more than 17,000 tissue and blood samples taken from patients with 35 types of cancer. They found that fungi can be detected in all of these cancer types. Fungi were mostly found “hiding” inside the cancer cells or in immune cells inside the tumors.
Sep 29, 2022...
Look up an image of a tumor on Google, and you’ll probably end up with a brightly colored cluster of cancer cells on a drab background of healthy tissue. A tumor may also contain millions of microbes, representing dozens of species.
“I think this is an ecosystem,” she said. “It means the cancer cells are not alone.”
Scientists have long known that our bodies are home to microbes, but have tended to treat tumors as if they were sterile. In recent years, however, researchers have laid that notion to rest, demonstrating that tumors are rife with microbes.
https://www.weizmann-usa.org/news-media/feature-stories/a-new-avenue-for-breast-cancer-research/
Oct 19, 2022...
October is Breast Cancer Awareness Month. But at the Weizmann Institute, the focus on defeating this pervasive cancer is front and center every day, all year long.
Now, in exciting news, researchers at Weizmann, in collaboration with the National Cancer Institute in the U.S. and other institutions, have revealed a mechanism that accounts for the spread of a particularly aggressive type of breast malignancy. Cancers that spread rapidly are generally harder to treat, but clarifying the molecular basis of such aggressive cancers may lead to new drugs for treating these fast-growing malignancies.
https://www.weizmann-usa.org/news-media/in-the-news/expanding-the-limits-of-the-possible-1/
Nov 07, 2022...
A rock star, a Paralympic swimmer, and a Nobel Prize in Physics laureate were among the nine recipients of honorary Doctor of Philosophy degrees from the Weizmann Institute of Science on Monday, November 7, bestowed upon them in recognition of their extraordinary contributions to society.
"Each one of tonight’s honorees has expanded the limits of the possible, while inspiring others to fulfill their own boundless potential," Prof. Alon Chen, president of the Weizmann Institute, said at the conferment ceremony, hosted by news anchor Lucy Aharish on campus at the Michael Sela Auditorium. Part of the Institute’s 74th Annual General Meeting of the International Board, the ceremony and related events are taking place in person — and as usual — for the first time since the outbreak of the COVID-19 pandemic.
https://www.weizmann-usa.org/news-media/feature-stories/tumors-are-prime-real-estate-for-fungi/
Nov 13, 2022... Bacteria have been shown to affect cancer growth, metastasis, and response therapy, but now, according to a recently published study by Weizmann scientists, fungal activity is “a new and emerging hallmark of cancer,” says Prof. Ravid Straussman of the Weizmann’s Molecular Cell Biology Department and co-leader of a recent study by researchers at the Weizmann Institute and UC-San Diego. This discovery will likely lead to better outcomes in human survival of many different cancers.
Nov 21, 2022... Weizmann Scientist, Prof. Yonina Eldar of the department of Computer Science and Applied Mathematics, explains how Artificial Intelligence can be used to improve signal processing. Signal processing is a crucial component that enables many of the devices we use today including hearing aids and medical imaging equipment, like MRI, CT and X-ray, which can all greatly benefit from better imaging and resolution. Prof. Eldar’s specializes in developing algorithms for signal processing, and for the representation and transmission of information using advanced mathematical techniques. Her lab develops AI tools and to acquire and extract information and combine them with other modes like physics or medicine to pave the way to new technologies that can see, hear, and communicate beyond existing limits. Prof. Eldar’s innovations have helped to make ultrasound devices smaller, cheaper, and uploadable to the cloud; optimize MRI scans for medical imaging, improve data storage and communications, create super-resolution microscopy, and support computational biology.
https://www.weizmann-usa.org/news-media/in-the-news/2022-breakthroughs-of-the-year/
Dec 08, 2022...
Today, The Atlantic reveals its inaugural 10 Breakthroughs of the Year. The accomplishments span every station of life, from birth to death, and every component, from our cells to the stars. They include a drug that revives the organs of dead animals; an embryo created without sperm or egg; a telescope to see the universe’s first moments; and an AI that conjures award-winning art.
One theme of this year’s list is the principle of “twin ideas”—the tendency for major breakthroughs to have more than one author. The telegraph was invented by Charles Wheatstone and Samuel Morse in the same year, 1837, and patents for the telephone were filed by Elisha Gray and Alexander Graham Bell on the same day in 1876. Accordingly, many of this year’s breakthroughs are group efforts rather than individual awards. We didn’t just get one mind-blowing generative AI app this year; we got several in the span of a few months. We didn’t just get one “unheard-of” cancer breakthrough; we got several in one year. In this golden age of new vaccine technology, many different companies are building off the success of the COVID shots to deliver new antiviral weaponry for humankind.
https://www.weizmann-usa.org/news-media/in-the-news/scientists-debut-lab-models-of-human-embryos/
Jun 24, 2023... Scientists Debut Lab Models of Human Embryos
Aug 07, 2023...
REHOVOT, ISRAEL — August 8, 2023—Nonsmokers who develop lung cancer can be treated effectively with new drugs, but their tumors refuse to surrender without a fight. The drugs stop working in the long term because the tumors acquire secondary mutations that allow them to evade the medications’ therapeutic effect.
In research published today in the journal Cell Reports Medicine, investigators from the Weizmann Institute of Science report findings that may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists identified a biomarker that may help physicians treat select lung cancer patients with a single antibody-based drug that is likely to bring about full remission, without cancer relapse.
Aug 08, 2023...
To protect itself against disease, the human body has immune cells that patrol like police officers, entering disease cells and destroying them. But some dangerous cells, including some solid tumors, operate in stealth and cannot be targeted by the body’s regular immune system.
Edity Therapeutics, an Israeli startup founded in 2019, reprograms a patient’s own immune cells, giving them the ability to hunt down and destroy these cancer cells. It’s like transforming regular beat cops into lethal supersleuths.